Small Financial Statements From 2010 to 2024
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Check Small Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Small Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Small financial statements analysis is a perfect complement when working with Small Pharma Valuation or Volatility modules.
Small |
Small Pharma OTC Stock Shares Outstanding Analysis
Small Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Small Pharma Shares Outstanding | 321.56 M |
Most of Small Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Small Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Small Pharma has 321.56 M of shares currently outstending. This is 78.12% higher than that of the Healthcare sector and 200.93% higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is 43.77% higher than that of the company.
Small Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Small Pharma's current stock value. Our valuation model uses many indicators to compare Small Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Small Pharma competition to find correlations between indicators driving Small Pharma's intrinsic value. More Info.Small Pharma is rated # 4 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Small Pharma's earnings, one of the primary drivers of an investment's value.About Small Pharma Financial Statements
Small Pharma stakeholders use historical fundamental indicators, such as Small Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Small Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Small Pharma's assets and liabilities are reflected in the revenues and expenses on Small Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Small Pharma. Please read more on our technical analysis and fundamental analysis pages.
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |